Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» liver disease
liver disease
Mirum Pharmaceuticals Files for $63 Million Offering
CP WIre
Wed, 01/8/20 - 10:44 am
Mirum Pharmaceuticals
liver disease
Dicerna scores broad, 'rest of liver' deal with Novo Nordisk, bagging $225M in cash to hit some 30 targets with RNAi platform
Endpoints
Mon, 11/18/19 - 11:33 pm
Dicerna
Novo Nordisk
liver disease
RNAi
3 Things to Watch From the Pharmaceutical Industry's Liver Meeting
Motley Fool
Wed, 10/23/19 - 10:40 am
liver disease
NASH
The Liver Meeting
Assembly Biosciences
CymaBay Therapeutics
Madrigal Pharmaceuticals
In $86M IPO pitch, Mirum spells out plans to turn Shire discards into orphan liver drug successes
Endpoints
Mon, 06/24/19 - 11:14 am
Mirum
IPOs
Shire
liver disease
Researchers ID 14 Genes Linked to Survival in Pediatric Liver Disease
BioSpace
Wed, 06/19/19 - 11:36 pm
pediatric
liver disease
genes
biliary atresia
Will a big needle burst the NASH bubble?
Biopharma Dive
Tue, 05/14/19 - 11:41 pm
diagnostics
liver disease
NASH
liver biopsies
Intercept Tries to Outrun Pharma in Race for the Next Blockbuster
Bloomberg
Thu, 04/11/19 - 07:27 pm
liver disease
NASH
Intercept Pharmaceuticals
OCA
obeticholic acid
Pfizer buys stake in French gene therapy firm Vivet
CNBC
Wed, 03/20/19 - 09:57 am
Pfizer
M&A
Vivet
gene therapy
liver disease
Gilead's search for the next great liver drug won't end with its FXR agonist
Biopharma Dive
Sat, 11/10/18 - 12:01 pm
Gilead Sciences
liver disease
GS-9674
Cash for NASH: 2 Top Biotech Takeover Targets and 3 Potential Buyers
Motley Fool
Fri, 06/15/18 - 07:04 pm
NASH
liver disease
Viking Therapeutics
Madrigal Pharmaceuticals
Pfizer
Bristol-Myers Squibb
Gilead Sciences
Pfizer Selects Final Two Targets in Hepatic Disease Partnership with Wave Life Sciences
Genentic Engineering and Biology News
Mon, 05/7/18 - 10:22 pm
liver disease
Pfizer
Wave Life Sciences
NASH
Conatus Pharma’s Liver Disease Drug Flunks First Phase 2 Test
Xconomy
Thu, 04/5/18 - 11:57 pm
Conatus Pharmaceuticals
clinical trials
Novartis
emricasan
liver disease
hepatitis C
FDA adds black box warning to Intercept's Ocaliva
Biopharma Dive
Thu, 02/1/18 - 09:32 pm
FDA
black box
Intercept Pharma
Ocaliva
liver disease
5 Ways Gilead Sciences Plans to Return to Growth
Motley Fool
Tue, 01/9/18 - 10:55 pm
Gilead Sciences
HIV
liver disease
cell therapy
inflammation
M&A
FDA Warns Doctors After 19 Deaths on Intercept Liver Drug
Bloomberg
Fri, 09/22/17 - 09:16 am
FDA
Intercept Pharma
Ocaliva
liver disease
Cempra Releases Promising Phase II Clinical Trial Results For Anti-NASH Drug
Xtalks
Wed, 10/5/16 - 05:25 pm
Cempra
clinical trials
NASH
liver disease
Solithromycin
Allergan just acquired two companies in one day
Yahoo/Business Insider
Tue, 09/20/16 - 08:54 pm
Allergan
M&A
liver disease
NASH
Akarna Therapeutics
Tobira Therapeutics
2 Hotly Debated Drugs Due For FDA Decisions Next Week
Investors.com
Sat, 05/21/16 - 12:35 pm
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Intercept Pharma
Ocaliva
liver disease
primary biliary cholangitis
Rare liver disorder drug from Jazz wins U.S. approval
Yahoo/Reuters
Wed, 03/30/16 - 09:19 pm
Jazz Pharmaceuticals
FDA
hepatic veno-occlusive disease
liver disease
Defibrotide
2015's Worst Clinical Failures
Motley Fool
Sat, 12/12/15 - 02:01 pm
clinical trials
liver disease
cancer pain
Eli Lilly
Intercept Pharmaceuticals
GW Pharma
Pages
« first
‹ previous
1
2
3
next ›
last »